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Abstract.  Hematopoietic stem cells (HSCs) are 
characterized by their ability to differentiate into all 
hematopoietic cell lineages while retaining their ca- 
pacity for self renewal. One of the predictions of this 
model is the existence of a  heterogeneous pool of 
HSCs,  some members of which are destined to be- 
come lineage restricted progenitor cells while others 
function to renew the stem cell pool.  To test whether 
HSCs are heterogeneous with respect to cell cycle sta- 
tus, we determined the fraction of phenotypically 
defined murine HSCs (Thyl.11° Lin  -~° Sea-1 +) that con- 
tain >2n amount of DNA as measured by propidium 
iodide staining, Hoechst dye uptake and [3H]thymidine 
labeling; that fraction is  18-22%.  In contrast, in the 
developing fetal liver, 40%  of HSCs are in the 
S/G2/M phases of the cell cycle. Those HSCs which 
exhibit a  low level of staining with rhodamine 123  are 
almost exclusively in G0/G1  (97%) whereas only 70% 
of HSCs which stain brightly for rhodamine 123  are 
in G0/G1. The injection of 100 G0/G1  HSCs rescued 
90%  of lethally irradiated mice in contrast to  100 
S/G2/M HSCs, which protected only 25 % of lethally 
irradiated recipients.  Enhanced long-term donor- 
derived multilineage reconstitution of the peripheral 
blood was observed in recipients of 100 G0/G1  HSCs 
compared to recipients of 100 S/G2/M cells. These 
data indicate that a  significant proportion of HSCs are 
actively proliferating during steady state hematopoiesis 
and that this subpopulation of cells exhibits reduced 
stem cell activity. 
H 
EMATOPOIETIC stem cells (HSCs) t are a population 
of cells, each of which can give rise to all blood cell 
lineages; contained within this population are cells 
that  are  radioprotective  and  are  capable  of self-renewal 
(Spangrude et ai., 1991). This model predicts the existence 
of a heterogeneous pool of HSCs, some members of which 
are destined to become lineage restricted progenitor cells 
while others function to renew the stem cell pool. To test for 
this functional heterogeneity we first examined the cell cycle 
status of phenotypieally defined murine hematopoietic stem 
cells. A rare ('~0.05%) population of mouse bone marrow 
cells  characterized phenotypically by the  surface marker 
profile Thyl.1  ~° Lin  -~° Sea-1  + has been isolated previously 
and shown to contain all the above properties (Spangrude et 
al., 1988). These cells are 1,000-2,000-fold enriched for day 
12 CFU-S (Till and McCulloch, 1961; Magli et al.,  1982), 
radioproteetion, and long-term multilineage reconstitution 
of lethally irradiated congenie hosts (Spangrude et al., 1988; 
Uchida and Weissman, 1992).  Single cells give rise to all 
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1. Abbreviation  used in this paper: HSCs, hematopoietic  stem cells. 
lineages tested including T-cells,  B-cells, and myelomono- 
cytic cells and can self-renew (Smith et al.,  1991; Uchida, 
N., and I. L. Weissman, manuscript in preparation), 
We had reported previously that only 2-3 % of bone mar- 
row cells of this phenotype contained >2n mounts of DNA 
as shown by propidium iodide staining (Spangrude et al., 
1988).  This finding was consistent with several studies in- 
cluding the relative resistance of inferred HSCs to cell cycle 
specific chemotherapeutic agents such as 5-FU (Bruce and 
Meeker, 1967);  the demonstration that in whole bone mar* 
row transplants, repopulation can be oligoclonal (Keller et 
al.,  1985; Dick et ai.,  1985; Jordan and Lemishka, 1990); 
the general proposition that there is a limit of'x,40 doublings 
for nontransformed cells (Hayflick, 1965) as well as a corre- 
sponding limit to the number of serial bone marrow trans- 
plants that are radioprotective (Ross et al., 1982). In conflict 
with this conclusion is the demonstration that by several 
measures of hematopoiesis, inferred HSCs contain 20-30% 
of cells that are susceptible to the effects of tritiated thymi- 
dine suicide or hydroxyurea (Necase et al., 1989).  Further- 
more, significant heterogeneity in the mouse HSC pool in 
terms of self  renewal potential has been found in experiments 
on single cell Thyl.1  l° Lin  -/~° Sea-1  + seedings (Smith et al., 
1991).  When these cells  were stained with the vital dye 
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1231° cells appear to self renew to a much greater degree 
than the Rh-123  h~ cells (Spangrude and Johnson,  1990). 
We therefore examined the functional significance of the 
cell cycle status of C57BL/Ka Thyl.1, Thyl.P  ° Lin  -/1° Sea-1 + 
hematopoietic ceils.  We show here that the  frequency of 
bone marrow derived S/G2/M HSCs is  18-22%, while at 
least 40% of fetal liver HSCs are actively proliferating. The 
S/G2/M fraction of HSCs demonstrate a reduced capacity 
for both radioprotection and long-term, donor-derived mul- 
tilineage  reconstitution  of  the  peripheral  blood.  These 
findings are consistent with  the proposition that many of 
these S/G2/M cells are now destined to complete a program 
of terminal  differentiation and  are  no  longer  capable  of 
renewing the stem cell pool. 
Materials and Methods 
Mice 
The C57BL/Ka-Thyl.1  (Thyl.1,  Ly5.2)  strain was used as the source of 
whole bone marrow, fetal liver and bone marrow derived stem cells in these 
studies. The C57BL/6J-Ly5.I-Pep  3b strain was used as congenic recipients. 
Animals were bred and maintained in the mouse facility at Stanford Univer- 
sity (Stanford, CA). 
Cell Preparations 
Bone marrow stem cell preparations were obtained by flushing the tibias and 
femurs of 4-6 wk old animals followed by a series of purification steps out- 
lined previously (Spangrude et al., 1988). Briefly, cells that express low lev- 
els of the Thyl.1  antigen, high levels of Sea-1 (Ly6A/E) antigen, and nega- 
tive or low levels of  the following lineage markers: CD3, CIM, CD8, Mac-l, 
GR-1, B220,  and TER-119,  were isolated using fluorescence-activated cell 
sorting (FACS).  Labeled cells were analyzed and sorted using a modified 
dual laser FACS  ® II (Becton Dickinson, San Jose, CA). Day 14 fetal liver 
cells were harvested and Thyl.1 t° Lin  -n° Sea-1 + cells enriched as described 
previously (Ikuta and Weissman, 1992).  In some experiments, bone mar- 
row derived stem cells were stained with rhodamine 123 as described previ- 
ously (Bertonceilo et al., 1985;  Spangrude and Johnson, 1990) before cell 
cycle analysis. 
Cell Cycle Analysis 
Cell suspensions were lysed in a  solution containing  1%  Triton X-100, 
RNase 100 #g/ml, and propidium iodide (PI) 10 ~g/ml. Nuclei were then 
analyzed for DNA content by FACS  ® (Taylor,  1980).  Alternatively, cells 
were incubated with Hoechst 33342 dye (Sigma Chemical Co., St. Louis, 
MO) at a concentration of 5 ug/ml then analyzed for DNA content by FACS 
(Hamori et al.,  1980). 
Thymidine Labeling 
Bone marrow derived Thyl.1 l° Lin  -n° Sea-1  + cells were incubated with 10 
t~Ci of [3H]thymidine (Specific activity 20 Ci/mmol, New England Nu- 
clear, Boston, MA) for 30 rain at 370C,  rinsed twice in HBSS, and then 
cytospin preparations were made.  Slides were coated with photographic 
emulsion (NTB2, Eastman Kodak Co.) and then stored at 4"C for 8--14 d 
developed, then counter stained with hematoxylin. Percent labeling was de- 
termined after counting 400 cells. Those cells with more than 10 grains 
above background were considered positive (average background was two 
grains/cell). 
Radioprotection Assay 
Recipient mice were lethally irradiated using a Phillips 250 IN x-ray ma- 
chine at 1 Gy/min in two fractions at least 3 h apart to a total of 8.5 Gy. 
Suspensions of sorted cells from adult bone marrow were injected in a vol- 
ume of 200 t~l into the retro-orbital sinus under methoxyflurane anesthesia. 
Animals were maintained on aqueous antibiotics (polymyxin B  sulphate 
106 U/liter and neomycin sulphate 1.1 g/liter) in their drinking water. Re- 
cipient mice were monitored daily for survival for 30 d. 
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Figure 1.  DNA content of bone marrow derived stem cells. Cells 
were lysed and the nuclei stained with propidium iodide and the 
DNA content determined by FACS.  (A) Total bone marrow ceils. 
(B) Purified Thyl.1 L° Lin  -/l° Sea-1 + cells (HSCs).  Percentage of PI 
labeled nuclei in S/G2/M is indicated. 
Long-Term Reconstitution Assay 
The donor and recipient mice used were congenic at the Ly-5 locus (CD45). 
Peripheral blood was obtained from the retroorbital sinus under methoxy- 
flurane anesthesia and stained with a panel of antibodies. Using FACS anal- 
ysis the percentage of B cells (B220+),  T cells (CD3  +) and myeloid cells 
(Gr-l+/Mac-l+), that were donor derived (Ly5.2  +) was determined (Span- 
gruda et al.,  1988). 
Competitive Repopulation Assay 
Lethally irradiated Ly5.1 recipient mice were injected with 2  x  105 syn- 
geneic bone marrow cells and either 10 G0/G1  or 100 S/G2/M Thyl.1 i° 
Lin  -/l° Sea-1  + stem cells (Ly 5.2).  The degree of donor-derived long-term 
reconstitution was determined as described above. 
Results 
Cell Cycle Status of Bone Marrow-derived 
Hematopoietic Stem Cells 
During the course of experiments designed to evaluate the 
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Figure 2.  Hoechst 33342  staining of Thyl.1 ~° Lin  -/l° Sea-1 + cells. 
Sorted viable HSCs were incubated with Hoechst dye and uptake 
was analyzed by FACS  °. The percentage of cells in S/G2/M is indi- 
cated. 
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diograph of  tritiated thymidine labeled HSCs from adult bone mar- 
row. Of a total of 400 cells examined, 12-15% were labeled (ar- 
rows). Exposure time was 8 d. (x  800) 
cell cycle status of Thy~ Lin  -~° Sea-1 + cells, the observation 
was made by Mr. Tim Knaak, Stanford FACS  ®  operator, that 
a large number of events recorded by the cell sorter during 
the analysis of propidium iodide stained nuclei were neither 
excluded by forward scatter gates nor readily apparent in the 
major peak of 2n nuclei. Gating around the S/G2/M popula- 
tion and expressing this value as a percentage of total events 
lead to a  significant underestimation of the proportion of 
cells in S/G2/M (Spangrude et al.,  1988). These extra sig- 
nals are presumably due to the presence of magnetic beads 
in the cell lysate. Sorting these cells without magnetic beads 
as shown in Fig. 1, demonstrates that 28 % of unfractionated 
bone marrow cells and 22% of Thyl.1  t° Lin  -n° Sca-1 + cells 
are in the S/G2/M phase of the cell cycle based on their con- 
tent of propidium iodide stained DNA. The DNA content of 
viable HSCs was determined using  the vital dye Hoechst 
33342,  and  as  shown  in  Fig.  2,  18%  of Thyl.1  ~°  Lin  -n° 
Sea-1 + cells contain >2n amounts of DNA.  The similarity 
in the PI and Hoechst 33342 staining effectively  rules out any 
underestimation of cycling cells that may result from the ac- 
tive transport of Hoechst dye from cells by the MDR gene 
product (Chaudhary and Roninson,  1991).  This high per- 
centage of cycling cells is confirmed by tritiated thymidine 
labeling of purified Thyl.P  ° Lin  -n° Sea-1 + ceils followed by 
autoradiography. An analysis of  400 cells per experiment in- 
dicates that 12-15% of these cells are actively synthesizing 
DNA (Fig.  3). 
Cell Cycle Status of Fetal Hematopoietic Stem Cells 
Analysis of the DNA content of day  14 fetal liver cells by 
propidium iodide staining indicates that 44 % of these cells 
are in the S/G2/M phase of the cell cycle (Fig. 4 b). Deple- 
tion of those cells which express the erythroid marker TER- 
119 results in a cell population enriched for HSCs and other 
progenitors  which  are  predominantly  (59%)  in  S/G2/M 
(Fig. 4 c). Subsequent purification of Thyl.1  ]° Lin  -/'° Sea-1  + 
cells from this enriched population yields a subset of highly 
purified HSCs, 40% of which are in S/G2/M (Fig. 4 d). The 
percentage  of day  14  fetal  liver  derived  Thyl.P  °  Lin  -a° 
Sca-1 + cells in S/G2/M is therefore nearly twice that found 
in normal adult bone marrow derived HSCs (40% vs 22%). 
This finding is consistent with the rate of increase in fetal 
liver derived HSCs observed during this period of fetal de- 
velopment (Ikuta and Weissman,  1992). 
Cell Cycle Status of  Rhodamine 123 Stained 
Hematopoietic Stem Cells 
Rhodamine-123 uptake has been used to fractionate hemato- 
poietic  progenitors  into  Rh-123  j°  vs  Rh-123  ~  subpopula- 
tions  (Bertoncello et al.,  1985;  Spangrude  and  Johnson, 
1990; Visser et al.,  1981).  The Rh-123  ~° subset appears to 
be enriched for more primitive HSCs  in  both the mouse 
(Spangrude and Johnson,  1990;  Baines and Visser,  1983) 
and human (Baum et al., 1992). We therefore wished to ana- 
lyze  cell  cycle  status  of  Rh-123  ~°  and  Rh-123  ~  Thyl.P  ° 
Lin  -/~° Sea-1 + adult bone marrow cells. The further fraction- 
ation of Thyl.P  ° Lin  -n° Sea-1 + cells on the basis of Rh-123 
staining followed by analysis of DNA content demonstrates 
that only 2.9% of Rh-123  ~° cells are in S/G2/M (Fig. 5). In 
contrast,  30%  of Rh-123  ~  cells  contain  >2n  amounts  of 
DNA, and therefore at least that percentage are actively cy- 
cling. 
Stem Cell Activity of GO~G1 and S/G2/M Thyl.l ~ Lin  -~° 
Sca-1  +  Hematopoietic Stem Cell Subsets 
To  test  directly  the  functional  capacity  of  proliferating 
Thyl.11° Lin  -/~° Sea-1 +,  these cells were fractionated based 
on Hoechst 33342 staining, injected into lethally irradiated 
recipient mice and then survival was monitored daily for 30 
d. Fig. 6 demonstrates that 100 G0/G1 cells provided radio- 
protection to 90 % of lethally irradiated recipients while 100 
S/G2/M cells protected only 22% of recipients (animals that 
survived for 30 d continued to survive for at least 6 mo). At 
6 mo post transplantation, recipient mice were examined for 
the presence of donor-derived multilineage reconstitution of 
the peripheral blood (Table I).  In mice reconstituted with 
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DNA Content (Propidium Iodide) 
DI4FL Sea  + 
D  1  40%  Figure 4. DNA content of fe- 
tal liver HSCs. (A) Total adult 
bone marrow. (B) Total day 14 
fetal liver cells (D14FL). (C) 
D14FL cells after depletion of 
erythroid  cells.  (D)  D14FL 
Thy  I° Lin  -n° Sca-1  + cells. The 
percentage  of  PI  labeled 
nuclei in S/G2/M is indicated. 
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Figure  5.  DNA  content  of 
rhodamine 123 stained HSCs. 
Thyl.P  °  Lin  -/~° Sea-1  +  were 
further  sorted  based on rhoda- 
mine 123 staining,  lysed  and 
the nuclei were stained with 
propidium  iodide. (A)  Rh- 
123  t°  HSCs.  (B)  Rh-123  hi 
HSCs.  Percentage  of PI la- 
beled nuclei  in S/G2/M is in- 
dicated. 
100 G0/G1 cells, 34% of B cells,  16% of myeloid cells and 
19 % of T cells were donor-derived. In contrast, in recipients 
of 100 S/G2/M cells, only 7.8 % of B cells and <2.0 % of both 
myeloid cells and T  cells were donor-derived.  When  300 
G0/G1 cells were injected, survival was 100% (n =  10) and 
the majority of cells in all three lineages were donor-derived. 
After the injection of 300  S/G2/M cells,  similar levels of 
donor-derived reconstitution were observed and survival was 
increased to 50%  (n  =  8) (Table I). 
To demonstrate that the decreased radioprotective capac- 
ity of the S/G2/M cells was itself not responsible for the de- 
crease in donor-derived long-term reconstitution capacity of 
S/G2/M cells, we employed a competitive repopulation as- 
say  (Harrison,  1980).  Lethally  irradiated  recipient  mice 
were injected with 2  x  1@ syngeneic bone marrow cells 
and either 100 G0/GI or 100 S/G2/M cells. This dose of syn- 
geneic bone marrow provides radioprotection to the recipi- 
ent mice while permitting the G0/G1 and the S/G2/M cell 
subsets to undergo lineage specific differentiation. Recipient 
mice were analyzed 9 mo postinjection.  When  100 G0/G1 
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Figure 6. Radioprotective capacity of G0/G1 and S/G2/M HSCs. 
Thy  t° Lin  -n° Sca-1  + cells were incubated with Hoechst 33342 dye 
and further sorted based on their DNA content.  Either G0/G1 or 
S/G2/M HSCs fractions were then injected into lethally irradiated 
recipient  mice and  survival was monitored  daily  for 30 d.  (100 
G0/G1 HSCs o o,  100 S/G2/M  HSCs -e-~). 
cells were injected along with syngeneic bone marrow (Table 
II), 24 % of B cells, 19 % of T cells, and 23 % of myeloid cells 
were donor derived.  Recipients of 100  S/G2/M  cells and 
syngeneic bone marrow demonstrated less than 2% donor- 
derived peripheral blood cells. Together these results dem- 
onstrate that stem ceils in the S/G2/M phases of the cell cycle 
have  a  diminished  capacity  for both  radioprotection  and 
long-term  multilineage  reconstitution  of  the  peripheral 
blood. 
Discussion 
Using three independent techniques we have provided evi- 
dence that during steady state hematopoiesis in adult bone 
marrow, and in the developing fetal liver, a significant frac- 
tion of Thyl.P  ° Lin  -n° Sca-I  + ceils are actively proliferating. 
Table L Donor-derived Multilineage Reconstitution 
B220  MAC-1/GR-1  CD3 
56 Donor 
100 G0/G1  34.1  ±  11.7  15.6  ±  12.6  18.9  ±  9.0 
100 S/G2/M  7.8  ±  4.7  1.1  +  0.4  1.6  ±  0.5 
300 G0/G1  70.3  ±  18.5  58.0  ±  21.8  53.4  +  15.4 
300  S/G2/M  73.7  ±  23.3  36.0  +  24.2  43.9  ±  18.2 
Lethally irradiated  congenic recipient  mice were injected with either  100 or 
300 G0/G1 or S/G2/M  HSCs.  The percentage  of donor-derived  (Ly5.2 +) B 
cells  (B220+),  myeloid  cells  (Mac-1/GR-I+),  and  T  cells  (CD3  +)  in  the 
peripheral  blood  was determined  after  24  wk.  The  mean +  SEM  is  shown 
(n  =  4-10 mice per group). 
Table II.  Competitive Repopulation with GO~G1 
and S/G2/M HSCs 
B220  MAC- 1/GR-  1  CD3 
56  Donor 
lO0 GO~G1  23.5  ±  20.4  23.1  ±  20.6  19.1  +  17.2 
100  S/G2/M  1.7  ±  0.5  1.9  ±  0.5  1.6  ±  0.4 
Lethally irradiated recipient mice (Ly5.1) were injected  with 2  x  I0  s syn- 
geneic BM cells and coinjected with either  100 congenic G0/(31 HSCs or 100 
congenic  S/G2/M  HSCs.  The percentage  of HSC-derived  (Ly5.2 +) B cells 
(B220+), myeloid cells (Mac-1/GR-I+),  and T cells (CD3  +) in the peripheral 
blood was determined after 9 mo. The mean  +  SEM is shown (n =  4 mice 
per group). 
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indicate that 20-30% of stem cell activity is susceptible to 
tritiated thymidine suicide or hydroxyurea  treatment (Necase 
et al.,  1989;  Quesenberry  and  Stanley,  1980;  Schofield, 
1979).  These data are also similar to the cell cycle studies 
of the  hematopoietic  progenitors  CFUs  and  HPP-CFC, 
which  reveal  that  12-24%  of these cells  are  in  S/G2/M 
phases  of the cell cycle (Visser  et al.,  1981; Baines and 
Visser,  1983). 
As judged by the functional differences between GO/G1 
and  S/G2/M  HSCs,  there  is  considerable  heterogeneity 
within this phenotypically defined stem cell compartment. 
Previous studies have shown that it is possible to divide this 
highly enriched population into two groups based on stain- 
ing with the vital fluorescent dye Rh-123  (Spangrude and 
Johnson, 1990).  Rh-123 initially was thought to stain mito- 
chondria preferentially and therefore be a marker for meta- 
bolically active cells (Bertoncello et al.,  1985); however, it 
has been shown that low levels of Rh-123 staining of human 
hematopoietic progenitor cells may be the result of the ex- 
pression of the P-glycoprotein (Chaudhary and Roninson, 
1991)  which  confers the  multidrug  resistance  phenotype 
(MDR).  Those Thyl.1  ~° Lin  -n° Sca-1  ÷ cells which take up 
low levels of Rh-123 are enriched for the properties of radio- 
protection and long-term reconstitution of the peripheral 
blood of lethally irradiated mice after transfer to secondary 
recipients  (Spangrude  and  Johnson,  1990).  In  contrast, 
those cells which have a high level of Rh-123 staining do not 
exhibit this activity. While the mechanism of low levels of 
Rh-123 staining in these cells is not known, from this experi- 
ment it is apparent that Rh-123 staining permits the separa- 
tion of Rhq23  j°, mainly noncycling Thyl.1  ~° Lin  -n° So-1 + 
cells from the total population. It is important to note that 
in the experiments cited above, the secondary transfer ex- 
periments were performed only 14 d after the first transfer 
(Spangrude and Johnson,  1990),  a  situation which likely 
places a marked proliferative stress on these cells. Recently, 
Li and co-workers have fractionated Lin- Sea-I ÷ cells on 
the basis of Rh-123 staining and have reported significantly 
greater long-term, donor-derived, multilineage reconstitu- 
tion in the Rh-123 ~° (67-73%)  vs Rh-123 h~ (1-2%)  subsets 
(Li and Johnson,  1992).  Taken together, these studies sug- 
gest that the majority of stem cell activity in these enriched 
populations is confined to the Rh-123 ~° subset. 
When we directly tested the G0/G1 and S/G2/M Thyl.l'° 
Lin  -/~° Sca-1  ÷ cell subsets, we found them to be heteroge- 
neous in terms of both radioprotective capacity and long 
term multilineage reconstitution potential.  The decreased 
long-term reconstitution capacity of the S/G2/M subset was 
also observed when these cells were coinjected with a radio- 
protective dose of syngeneic bone marrow. Whether the de- 
creased radioprotection and long-term reconstitution capac- 
ity associated with the S/G2/M subpopulation is the result 
of a loss of their differentiation potential/self-renewal capac- 
ity, or due to a defect in the homing of these ceils to a favor- 
able microenvironment remains to be determined.  These 
data are consistent with the hypothesis that S/G2/M HSCs 
are themselves heterogeneous, the majority of these cells 
differentiating into the committed progenitor cell pool while 
a  smaller subset is responsible for self renewal.  Alterna- 
tively, S/G2/M HSCs may be functionally homogeneous but 
have a reduced capacity to provide long-term multilineage 
reconstitution on a per-cell basis. 
As hematopoietic growth factors are more frequently uti- 
lized to enhance the recovery of peripheral blood counts fol- 
lowing high dose chemotherapy, and as retroviral vector sys- 
tems  are  being  evaluated  for  gene  therapy,  it  becomes 
increasingly  important  to  understand  the  developmental 
potential of actively proliferating versus resting hematopoi- 
etic stem cells. Furthermore, the experiments that lead to the 
conclusion that the hematopoietic system may operate by 
uni/oligoclonal expansion and clonal succession would pre- 
dict that the proliferating fraction of HSCs at any one time 
interval should be uniclonal, a hypothesis that could now be 
tested outside the context of retroviral marking of bone mar- 
row transplants. 
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